What happened
Ministers have announced a new competition for the NHS federated data platform, while keeping the current Palantir-led arrangement during the transition. Health minister James Frith told MPs on 16 November that the contract would end in March 2029. Labour and Liberal Democrat MPs pressed for an earlier exit using the 2027 break clause.S1S2R1
Ben Coleman urged the government to remove Palantir, calling it an “albatross” around the NHS. Chi Onwurah, who chairs the Commons science and technology committee, argued that an inability to use a break clause without disrupting care amounted to dependence on the supplier. Frith said the decision was based on measures of use, not the politics of suppliers' executives or their other customers.S1
Why it matters
Ending this agreement does not itself identify who will provide the next platform. Frith said British businesses would be encouraged to compete, with international suppliers also invited. The Guardian describes Palantir's role ending, while the Independent reports an open competition in which it could lose the contract; the parliamentary statement commits to the current contract's end and an open process.S1S2R1
The disagreement also concerns how much the existing system is used. Frith told MPs that 170 trusts had signed up, 142 were live and 137 were benefiting. The Guardian reports that NHS England removed a website claim about 137 benefiting trusts after it found 29 used the platform rarely or not at all. These accounts leave the benefits figure contested.R1S2
The background
A Palantir-led consortium won the contract in 2023, with investment of up to £330 million over seven years, NHS England announced. The Commons Library describes the platform as a way to connect existing datasets across organisations. Its functions include helping trusts manage waiting lists, schedule operations and plan services, rather than collecting every record into one central database.R4R2
The Independent reports concerns about how patient data would be used, alongside Palantir's contracts with US Immigration and Customs Enforcement and the Israeli military. Helen Morgan criticised the company's human-rights record, while John McDonnell accused it of human-rights abuses and sought a humanitarian criterion in the next procurement. Those are MPs' criticisms, not findings established in this account.S1
There are also defined limits on what the supplier may do with information. NHS England's published explanation says data remains under NHS control and Palantir cannot commercialise it, including in anonymised form, or use it to train its own AI products. These contractual restrictions are distinct from claims about whether the platform delivers better care.R3
Liberal Democrat health spokesperson Helen Morgan argued that distrust of Palantir was undermining participation. Palantir UK executive Tom Watson defended the programme, saying it helped deliver operations, speed discharge and shorten cancer-diagnosis waits. Shadow health secretary Damian Hinds argued that procurement should prioritise patient care, specifications and price over political preferences.S1
What happens next
Frith said procurement terms would be issued in the coming weeks, with market engagement from January. He described 18 to 24 months as a reasonable period for commissioning and procurement. The eventual suppliers, detailed requirements and transition arrangements will determine how the government's stated aim of reducing dependence on one provider is implemented.R1S1